Profil
Charity D.
Scripture served as the Chief Development Officer at Bellicum Pharmaceuticals, Inc. from 2019 to 2024.
Prior to that, she worked as the Vice President of Business and Development Operations at ACELYRIN, Inc. She completed her undergraduate degree at Hamilton College (New York), her graduate degree at Dartmouth Medical School, and her doctorate at the University of North Carolina at Chapel Hill.
Anciens postes connus de Charity Scripture
| Sociétés | Poste | Fin |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/02/2024 |
| ACELYRIN, INC. | Corporate Officer/Principal | - |
Formation de Charity Scripture
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Hamilton College (New York)
Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACELYRIN, Inc.
ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















